For details, please visit the following press releases.

Mediar Therapeutics Enters into a Collaboration and Option Agreement with Ono Pharma to Develop Novel Treatments for Fibro-inflammatory Disease
https://www.mediartx.com/wp-content/uploads/2026/08/Mediar_Ono-Collab-Release_FINAL.pdf

Ono Pharma Enters into a Drug Discovery Partnership with Mediar Therapeutics to Create Novel Antibody Therapeutics for Fibro-inflammatory Diseases
https://www.ono-pharma.com/en/news/20260806.html